INS and type 2 diabetes mellitus: Yu et al. reported a higher risk of HCC in patients with T2DM treated with insulin (RR, 18.5; 95% CI, 2.2–156.0) [108], and a meta-analysis performed by Singh et al. reported a 161% increased risk of HCC in patients treated with insulin [121].